Genmab A (GMAB) Divestments (2018 - 2020)

Genmab A's Divestments history runs 3 years deep, the most recent figure standing at -$2565.0 for Q3 2020.

• Quarterly Divestments rose 99.99% year-over-year to -$2565.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was -$460.6 million (changed N/A YoY) and the FY2019 annual result came in at -$1983.0, up 100.0% from the prior year.
• Divestments was -$2565.0 for Q3 2020 at Genmab A, down from -$46.0 in the prior quarter.
• Across five years, Divestments topped out at -$46.0 in Q4 2019 and bottomed at -$414.4 million in Q4 2018.
• A 3-year average of -$115.2 million and a median of -$23.1 million in 2019 frame the typical range for Divestments.
• Annual changes were most pronounced in 2019 — Divestments soared 100.0% — and 2020, when it jumped 99.99%.
• Genmab A's Divestments stood at -$414.4 million in 2018, then surged by 100.0% to -$46.0 in 2019, then tumbled by 5476.09% to -$2565.0 in 2020.
• Business Quant data shows GMAB's Divestments at -$2565.0 in Q3 2020, -$46.0 in Q4 2019, and -$46.2 million in Q3 2019.